Company Spotlight

NDH Medical Inc.

11001 Roosevelt Boulevard North
Suite 800
Saint Petersburg, FL 33716-2338
United States
View Profile

maxon

125 Dever Drive
Taunton, MA 02780
United States
View Profile

Qosina Corp.

2002-Q Orville Drive North
Ronkonkoma, NY 11779
United States
View Profile


Outsourcing Directory


CP Medical





Company Headquarters

1775 Corporate Drive
Suite 150
Norcross, GA 30093
United States

Outsourcing Directory

    Related Content

    • Cardiovascular
      FDA Approves Abiomed

      FDA Approves Abiomed's Next-Gen Impella RP for Right Heart Failure

      Safe and effective to treat acute right heart failure for up to 14 days.
      Business Wire 06.29.21

    • Cardiovascular
      Study Links 79 Percent Survival Rate to Impella 5.5 With SmartAssist

      Study Links 79 Percent Survival Rate to Impella 5.5 With SmartAssist

      Data show an 86 percent survival rate for cardiomyopathy cardiogenic shock patients.
      Michael Barbella, Managing Editor 02.08.21

    • New Clinical Trial Data Supports BD Libertas Wearable Injector as a Drug Delivery System

      New Clinical Trial Data Supports BD Libertas Wearable Injector as a Drug Delivery System

      The results show the device effectively delivers dose volumes up to 5 mL subcutaneously.
      B3C newswire 01.08.21


    • Diagnostics | Digital Health | Patient Monitoring
      Philips Inks Two Long-Term Partnership Deals with German Hospital Groups

      Philips Inks Two Long-Term Partnership Deals with German Hospital Groups

      The deals represent two of Europe’s largest medical technology partnership agreements with German hospital groups.
      Philips 07.12.18

    • Diagnostics
      FDA Authorizes First Test for Emerging Pathogen Candida Auris

      FDA Authorizes First Test for Emerging Pathogen Candida Auris

      C. auris is a drug resistant yeast that can cause serious infections in hospitalized patients.
      U.S. Food and Drug Administration 04.23.18